Johnson & Johnson has been talking up the benefits of its JLABS incubator strategy for R&D collaboration for some time, and is now setting up a unit in Belgium to debut the approach in Europe.
A year ago the company revealed it had signed more than 230 partnerships with life science companies as a result of JLABS, with more than 200 companies operating at its then eight sites east and west coasts of US and Canada. In the last year it has seen the number of hosted companies swell to more than 330 and these have raised a whopping $9.4bn in capital.
